Noemí Escalera

发表

Response to letter regarding article, "effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial".

Armando Pérez de Prado, V. Fuster, S. Pocock, 2014, Circulation.

Long-term benefit of early pre-reperfusion metoprolol administration in patients with acute myocardial infarction: results from the METOCARD-CNIC trial (Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction).

V. Fuster, S. Pocock, A. Íñiguez, 2014, Journal of the American College of Cardiology.

Effect of Early Metoprolol on Infarct Size in ST-Segment–Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention: The Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) Trial

A. Íñiguez, J. Cabrera, P. López-Romero, 2013, Circulation.

Effect of Early Metoprolol on Infarct Size in ST-Segment Elevation Myocardial Infarction Patients Undergoing Primary PCI: The METOCARD-CNIC Trial

V. Fuster, S. Pocock, A. Íñiguez, 2013 .

Acute Coronary Syndrome Long-Term Benefit of Early Pre-Reperfusion Metoprolol Administration in Patients With Acute Myocardial Infarction Results From the METOCARD-CNIC Trial ( Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction )

V. Fuster, S. Pocock, A. Íñiguez, 2014 .

Intravenous metoprolol during ongoing STEMI ameliorates markers of ischemic injury: a METOCARD-CNIC trial electrocardiographic study

B. Ibáñez, J. Sanchez-González, G. Pizarro, 2021, Basic Research in Cardiology.

Early Intravenous Beta-Blockers in Patients With ST-Segment Elevation Myocardial Infarction Before Primary Percutaneous Coronary Intervention.

V. Fuster, J. Ottervanger, F. Fernández‐Avilés, 2016, Journal of the American College of Cardiology.

Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT).

B. Ibáñez, R. Latini, X. Rosselló, 2021, European heart journal. Cardiovascular pharmacotherapy.

(METOCARD-CNIC) Trial of Metoprolol in Cardioprotection During an Acute Myocardial Infarction Infarction Patients Undergoing Primary Percutaneous Coronary Intervention: The Effect Elevation Myocardial - Effect of Early Metoprolol on Infarct Size in ST-Segment

V. Fuster, S. Pocock, A. Íñiguez, 2013 .

Design of the β3-Adrenergic Agonist Treatment in Chronic Pulmonary Hypertension Secondary to Heart Failure Trial

V. Fuster, S. Pujadas, J. Barberà, 2020, JACC. Basic to translational science.

Design of the b 3-Adrenergic Agonist Treatment in Chronic Pulmonary Hypertension Secondary to Heart Failure Trial

V. Fuster, S. Pujadas, B. Ibáñez, 2022 .

Nutritional preconditioning by marine omega-3 fatty acids in patients with ST-segment elevation myocardial infarction: A METOCARD-CNIC trial substudy.

V. Fuster, B. Ibáñez, A. Fernández-Ortiz, 2017, International journal of cardiology.

Effect of Early Metoprolol on Infarct Size in ST-Segment–Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention: The Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) Trial

A. Íñiguez, J. Cabrera, P. López-Romero, 2013, Circulation.

Effect of Early Metoprolol on Infarct Size in ST-Segment Elevation Myocardial Infarction Patients Undergoing Primary PCI: The METOCARD-CNIC Trial

V. Fuster, S. Pocock, A. Íñiguez, 2013 .

Effect of Early Metoprolol on Infarct Size in ST-Segment Elevation Myocardial Infarction Patients Undergoing Primary PCI: The METOCARD-CNIC Trial

C. Macaya, A. Fernández-Ortiz, L. Fernandez-Friera, 2013 .

Effect of Early Metoprolol on Infarct Size in ST-Segment–Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention The Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) Trial

P. López-Romero, C. Macaya, A. Fernández-Ortiz, 2013 .

Rationale and design of RESILIENCE: A prospective randomized clinical trial evaluating remote ischaemic conditioning for the prevention of anthracycline cardiotoxicity.

Sandra Gómez-Talavera, N. Bolaños, Borja Ibáñez, 2024, European journal of heart failure.